According to immunohistochemistry (IHC), the cells are positive for SMA and MSA and aberrant nuclear beta-catenin expression (80% of sporadic desmoid fibromatosis and 67% for patients with FAP, and 56% of superficial fibromatosis). Here, CTNNB1 is linked to desmoid tumor.